Canigen L4

Authorised

This medicine is authorised for use in the European Union

canine leptospirosis vaccine (inactivated)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Canigen L4 : EPAR - Summary for the public

Product information

Canigen L4 : EPAR - Product Information

Canigen L4 : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Canigen L4
• Active substance:
  Inactivated Leptospira strains: L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000); L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001); L. interrogans serogroup Australis serovar Bratislava (strain As-05-073); L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
• International non-proprietary name (INN) or common name:
  canine leptospirosis vaccine (inactivated)

Authorisation details

• EMA product number:
  EMEA/V/C/004079

Assessment history

Changes since initial authorisation of medicine

Canigen L4 : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Canigen L4 : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Canigen L4

Adopted Reference Number: EMA/CVMP/259133/2015